Definitive Contract HHSN272201500003C
Award Date
2/16/15
Potential Completion Date
2/15/22
Potential Value
$8.1M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Starks Associates Inc.
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC Category
AN81 - R&D- Medical: Aids Research (Basic Research)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Buffalo, NY 14213, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Starks Associates Inc., a for-profit subchapter S corporation, by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). The contract, valued at $15,287,463.93, is for the resynthesis of therapeutic agents for the treatment of infectious diseases. The contract is a definitive contract with a cost-plus-fixed-fee pricing type and has a completion date of September 15, 2011. The contract is set...
This federal contract award is for the Department of Health and Human Services' National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) to support preclinical services for HIV therapeutics. The prime contractor, Starks Associates Inc., a for-profit subchapter S corporation, will conduct synthesis and acquisition of compounds for subsequent biological in vitro and in vivo testing. The work is being performed under a delivery order against an...
Starks Associates Inc. was awarded a $5,908.72 delivery order against the Preclinical Services for HIV Therapeutics master indefinite-delivery/indefinite-quantity (IDIQ) contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose of this task order is for Starks Associates to develop and deliver a quality assurance/quality control plan and participate in a task order initiation meeting to support preclinical services for HIV therapeutics....
This task order funds the guaranteed minimum amount under the prime contractor's Preclinical Services for HIV Therapeutics contract with the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Starks Associates Inc. will provide preclinical services in support of HIV therapeutic development work in Buffalo, New York for $0.00 through May 18, 2021. The underlying multiple award indefinite delivery/indefinite quantity contract vehicle was awarded on a cost-no-fee...
This federal contract award, valued at $499,879.67, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The contract is for the identification of lead compounds to inhibit HIV, as part of NIAID's broader "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract is a Delivery Order...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government, to the Institute for Defense Analyses (IDA), a nonprofit organization that operates Federally Funded Research and Development Centers (FFRDCs). The contract, valued at $80,237.08, is for AIDS research management and support services. It is a delivery order contract with a cost-plus-fixed-fee pricing type, without any set-aside designation....
This federal contract award is for the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases. The prime contractor is Southern Research Institute, a non-profit organization that provides advanced technologies and contract research services, including drug discovery and development, emerging infectious disease research, medicinal chemistry, and toxicology. The contract, with a potential value of $494,934.25, is...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The $999,976 cost-plus-fixed-fee contract is for services to identify inhibitors of HIV-1 capsid dimerization as part of NIAID's In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides program. The contract has no set-aside designation and is...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The $99,299 cost-plus-fixed-fee delivery order was placed under the Therapeutics Against Infectious Diseases Phase 1 IDIQ contract, which funds Phase I clinical trials for therapeutic products targeting infectious diseases. The prime contractor is Dynport Vaccine Company LLC, a subsidiary of General Dynamics...
This federal contract award to Curia Global Inc., doing business as AMRI, is for chemistry and manufacturing services related to the chemical synthesis and process optimization of the compound STF-1759. The award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract has a ceiling value of $411,404.73 and a period of performance through September 30, 2021. It is a cost-plus-fixed-fee...